Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastroesophageal reflux

The Journal of Pediatrics

Volumn 106, Issue 2, 1985, Pages 311-316

  Grill, Bruce B ^a,b,c   Craig Hillemeier, A ^a,b,c   Semeraro, Lucille A ^a,b,c   McCallum, Richard W ^a,b,c   Gryboski, Joyce D ^a,b,c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M;

CHILD; CLINICAL ARTICLE; DIAGNOSIS; DIGESTIVE SYSTEM; DRUG ACCUMULATION; DRUG THERAPY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMAN; INFANT; PRIORITY JOURNAL; STOMACH; THERAPY; VOMITING;

DOMPERIDONE; DRUG ADMINISTRATION SCHEDULE; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; GASTRIC EMPTYING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMANS; INFANT; MALE; PERISTALSIS;

EID: 0021949010     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(85)80315-2     Document Type: Article

References (29)

1. Esophageal and gastric motor abnormalities in gastroesophageal reflux during infancy
2. Use of bethanechol for the treatment of gastroesophageal reflux
3. Enhanced gastroduodenal motility in children
4. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients
5. Is dopamine an inhibitory modulator of gastrointestinal motility?
6. A dose response study of the effect of domperidone on gastric retention states in man
7. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation: A comparison with metoclopramide
8. Gastroesophageal reflux in infants and children: A useful classification and reliable physiologic technique for its demonstration
9. Delayed gastric emptying in infants with gastroesophageal reflux
10. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal diseases
11. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man
12. Mechanisms of gastroesophageal reflux in children
13. Effects of bethanechol on esophageal pH of infants with gastroesophageal reflux (GER)
14. Oesophageal acid clearance: One factor in the production of reflux oesophagitis
15. Experimental esophagitis in cats impairs lower esophageal sphincter pressure
16. Motility disturbances caused by esophagitis
17. Esophageal acid clearance in infants with gastroesophageal reflux
18. Dose-dependent stimulation of antroduodenal coordination by domperidone via specific dopamine-receptors
19. Chronic regurgitation and vomiting treated with domperidone (R33812), a multicenter evaluation
20. The effects of domperidone on gastric emptying of liquid in man
21. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry
22. Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidone
23. Domperidone, a specific in vitro dopamine antagonist devoid of in vivo central dopaminergic activity
24. Gynecomastia in a male infant given domperidone
25. Extrapyramidal reactions due to domperidone
26. Determinants of esophageal acid clearance in normal subjects
27. Results of treatment of gastroesophageal reflux with bethanechol
28. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux